Review
doi: 10.1016/j.spen.2007.07.005.
Deletion 22q11: spectrum of associated disorders
Affiliations
- PMID: 17980310
- DOI: 10.1016/j.spen.2007.07.005
Item in Clipboard
Review
Deletion 22q11: spectrum of associated disorders
Semin Pediatr Neurol.
2007 Sep.
Abstract
Velocardiofacial syndrome, also called Shprintzen syndrome or DiGeorge sequence, is one of the most common genetic disorders in humans. Caused by a microdeletion on chromosome 22, it manifests in a remarkable variety of symptoms in multiple systems. The most frequent anomalies involve palatal function, facial features and congenital cardiac defects. In addition, learning disabilities and psychiatric issues are common. The aim of this article is to provide a concise review of the clinical characteristics of this complex disorder. Recognition of the features associated with velocardiofacial syndrome allows for an inclusive diagnosis and more comprehensive care.
Similar articles
-
Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.Immunol Allergy Clin North Am. 2008 May;28(2):353-66. doi: 10.1016/j.iac.2008.01.003. Immunol Allergy Clin North Am. 2008. PMID: 18424337 Review.
-
[Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].Rev Med Chil. 2001 May;129(5):515-21. Rev Med Chil. 2001. PMID: 11464533 Spanish.
-
DiGeorge syndrome: new insights.Clin Perinatol. 2005 Dec;32(4):963-78, ix-x. doi: 10.1016/j.clp.2005.09.006. Clin Perinatol. 2005. PMID: 16325672 Review.
-
Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?Am J Med Genet. 1996 Aug 23;64(3):523-4. doi: 10.1002/ajmg.1320640303. Am J Med Genet. 1996. PMID: 8862634 No abstract available.
-
Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.Am J Med Genet. 2000 Apr 10;91(4):313-7. Am J Med Genet. 2000. PMID: 10766989
Cited by
-
Aerodynamic Study of Velopharyngeal Insufficiency in 22q11.2 Deletion Syndrome.J Pers Med. 2024 Jun 10;14(6):620. doi: 10.3390/jpm14060620. J Pers Med. 2024. PMID: 38929841 Free PMC article.
-
Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.Eur J Pediatr. 2013 Jul;172(7):927-45. doi: 10.1007/s00431-013-1964-0. Epub 2013 Feb 26. Eur J Pediatr. 2013. PMID: 23440478
-
BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1.BMC Med Genet. 2009 Dec 23;10:144. doi: 10.1186/1471-2350-10-144. BMC Med Genet. 2009. PMID: 20030804 Free PMC article.
-
Testing criteria for 22q11.2 deletion syndrome: preliminary results of a low cost strategy for public health.Orphanet J Rare Dis. 2019 Jun 3;14(1):123. doi: 10.1186/s13023-019-1098-1. Orphanet J Rare Dis. 2019. PMID: 31159889 Free PMC article.
-
A French multicenter study of over 700 patients with 22q11 deletions diagnosed using FISH or aCGH.Eur J Hum Genet. 2016 Jun;24(6):844-51. doi: 10.1038/ejhg.2015.219. Epub 2015 Oct 28. Eur J Hum Genet. 2016. PMID: 26508576 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
